Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression

被引:170
作者
Lahlou, Hicham [1 ]
Sanguin-Gendreau, Virginie [1 ]
Zuo, Dongmei [1 ]
Cardiff, Robert. D. [3 ]
McLean, Gordon W. [4 ]
Frame, Margaret C. [4 ]
Muller, William J. [1 ,2 ]
机构
[1] McGill Univ, Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Dept Biochem & Med, Montreal, PQ H3G 1Y6, Canada
[3] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA
[4] Beatson Inst Canc Res, Canc Res UK Beatson Labs, Glasgow G61 1BD, Lanark, Scotland
关键词
breast cancer; Cre recombinase; transgenic;
D O I
10.1073/pnas.0710091104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Elevated expression and activation of the focal adhesion kinase (FAK) occurs in a large proportion of human breast cancers. Although several studies have implicated FAK as an important signaling molecule in cell culture systems, evidence supporting a role for FAK in mammary tumor progression is lacking. To directly assess the role of FAK in this process, we have used the Cre/loxP recombination system to disrupt FAK function in the mammary epithelium of a transgenic model of breast cancer. Using this approach, we demonstrate that FAK expression is required for the transition of premalignant hyperplasias to carcinomas and their subsequent metastases. This dramatic block in tumor progression was further correlated with impaired mammary epithelial proliferation. These observations provide direct evidence that FAK plays a critical role in mammary tumor progression.
引用
收藏
页码:20302 / 20307
页数:6
相关论文
共 33 条
  • [1] Ahmed F, 2002, CANCER RES, V62, P7166
  • [2] Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
    Andrechek, ER
    Hardy, WR
    Siegel, PM
    Rudnicki, MA
    Cardiff, RD
    Muller, WJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3444 - 3449
  • [3] Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth
    Andrechek, ER
    White, D
    Muller, WJ
    [J]. ONCOGENE, 2005, 24 (05) : 932 - 937
  • [4] FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
    Benlimame, N
    He, Q
    Jie, S
    Xiao, DZ
    Xu, YJ
    Loignon, M
    Schlaepfer, DD
    Alaoui-Jamali, MA
    [J]. JOURNAL OF CELL BIOLOGY, 2005, 171 (03) : 505 - 516
  • [5] Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells
    Duxbury, MS
    Ito, H
    Zinner, MJ
    Ashley, SW
    Whang, EE
    [J]. SURGERY, 2004, 135 (05) : 555 - 562
  • [6] FAK regulates biological processes important for the pathogenesis of cancer
    Gabarra-Niecko, V
    Schaller, MD
    Dunty, JM
    [J]. CANCER AND METASTASIS REVIEWS, 2003, 22 (04) : 359 - 374
  • [7] Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo
    Ghiso, JAA
    [J]. ONCOGENE, 2002, 21 (16) : 2513 - 2524
  • [8] Integrin signalling during tumour progression
    Guo, WJ
    Giancotti, FG
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (10) : 816 - 826
  • [9] INDUCTION OF MAMMARY-TUMORS BY EXPRESSION OF POLYOMAVIRUS MIDDLE T-ONCOGENE - A TRANSGENIC MOUSE MODEL FOR METASTATIC DISEASE
    GUY, CT
    CARDIFF, RD
    MULLER, WJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (03) : 954 - 961
  • [10] Integrin-linked kinase: A cancer therapeutic target unique among its ILK
    Hannigan, G
    Troussard, AA
    Dedhar, S
    [J]. NATURE REVIEWS CANCER, 2005, 5 (01) : 51 - 63